Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine added to opium tincture maintenance for male sexual function
IRCT20230522058253N15Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Aug 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in opioid use disorder (OUD) and sexual dysfunction comparing N-acetylcysteine + opium tincture maintenance with Placebo + opium tincture maintenance (2 arms). Primary endpoints: Change in sexual function, Change in quality of life and 1 more. Started Aug 2026; status: completed.
02
Drugs
acetylcysteineopium tincture
03
Conditions
opioid use disorder (OUD)sexual dysfunction
Beyond the preview
Go deeper on IRCT20230522058253N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230522058253N15.